- Home
- PRPO vs NURO Comparison
PRPO vs NURO Comparison
Compare PRPO & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- NURO
- Stock Information
- Founded
- PRPO N/A
- NURO 1996
- Country
- PRPO United States
- NURO United States
- Employees
- PRPO N/A
- NURO N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- NURO Medical/Dental Instruments
- Sector
- PRPO Industrials
- NURO Health Care
- Exchange
- PRPO Nasdaq
- NURO Nasdaq
- Market Cap
- PRPO 9.9M
- NURO 8.2M
- IPO Year
- PRPO N/A
- NURO N/A
- Fundamental
- Price
- PRPO $6.65
- NURO $4.37
- Analyst Decision
- PRPO
- NURO
- Analyst Count
- PRPO 0
- NURO 0
- Target Price
- PRPO N/A
- NURO N/A
- AVG Volume (30 Days)
- PRPO 6.8K
- NURO 21.7K
- Earning Date
- PRPO 03-28-2025
- NURO 02-20-2025
- Dividend Yield
- PRPO N/A
- NURO N/A
- EPS Growth
- PRPO N/A
- NURO N/A
- EPS
- PRPO N/A
- NURO N/A
- Revenue
- PRPO $17,411,000.00
- NURO $3,767,764.00
- Revenue This Year
- PRPO $75.18
- NURO N/A
- Revenue Next Year
- PRPO N/A
- NURO N/A
- P/E Ratio
- PRPO N/A
- NURO N/A
- Revenue Growth
- PRPO 31.31
- NURO N/A
- 52 Week Low
- PRPO $4.31
- NURO $2.66
- 52 Week High
- PRPO $7.20
- NURO $4.73
- Technical
- Relative Strength Index (RSI)
- PRPO 56.65
- NURO 67.97
- Support Level
- PRPO $6.52
- NURO $4.16
- Resistance Level
- PRPO $6.90
- NURO $4.40
- Average True Range (ATR)
- PRPO 0.23
- NURO 0.09
- MACD
- PRPO 0.01
- NURO 0.03
- Stochastic Oscillator
- PRPO 63.22
- NURO 95.24
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.